Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001919101 | SCV002177536 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 7 | 2024-05-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg600*) in the MLH3 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MLH3 cause disease. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1412459). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004043368 | SCV002717262 | uncertain significance | not specified | 2024-10-04 | criteria provided, single submitter | clinical testing | The p.R600* variant (also known as c.1798C>T), located in coding exon 1 of the MLH3 gene, results from a C to T substitution at nucleotide position 1798. This changes the amino acid from an arginine to a stop codon within coding exon 1. This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. Based on the available evidence, the clinical significance of this variant remains unclear. |
Fulgent Genetics, |
RCV005006216 | SCV005635791 | uncertain significance | Endometrial carcinoma; Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer | 2024-05-23 | criteria provided, single submitter | clinical testing |